Intravesical valrubicin in the treatment of carcinoma in situ of the bladder

Author： Steinberg GD   Kuznetsov DD   O’Connor RC   Alsikafi NF  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.6, 2001-06, pp. : 1009-1013

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravesical valrubicin for bladder cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 268, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Contemporary Intravesical Treatment Options for Urothelial Carcinoma of the Bladder

By Brassell Stephen A.   Kamat Ashish M.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 10, 2006-11 ,pp. : 1027-1036

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

A Single Institution's 10 Year Experience of Treating High Grade Superficial Transitional Cell Carcinoma and Carcinoma In Situ of the Bladder with Intravesical BCG

By Meyer Jon-Paul   Persad Rajendra   Gillatt David A.  

UroOncology, Vol. 2, Iss. 4, 2002-01 ,pp. : 189-191

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Valrubicin

By Onrust S.V.   Lamb H.M.  

Drugs & Aging, Vol. 15, Iss. 1, 1999-07 ,pp. : 69-75

Adis International

Access to resources Recommend Favorite

The Treatment of High Grade Superficial Bladder Cancer and Carcinoma In Situ with BCG -- A Questionnaire Survey of Consultant Practice in England and Wales

By Meyer Jon-Paul   Persad Rajendra   Probert John L.   Gillatt David A.  

UroOncology, Vol. 2, Iss. 2, 2002-01 ,pp. : 77-80

Ashgate Publishing Ltd

Access to resources Recommend Favorite